Report Content
Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Diabetic retinopathy industry 3600 synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Type trends
2.1.3. Age group trends
2.1.4. Management trends
2.1.5. Distribution channel trends
2.1.6. Regional trends
Chapter 3. Diabetic Retinopathy Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 – 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing technological advancements in diabetic retinopathy surgical instruments in developed countries
3.3.1.2. Favorable reimbursement available for ophthalmologic surgeries in developed as well as developing economies
3.3.1.3. Rising prevalence of diabetes in Asia Pacific and other underdeveloped economies
3.3.1.4. Growing geriatric population in North America and Europe
3.3.2. Industry pitfalls & challenges
3.3.2.1. Post-surgical complications
3.4. Growth potential analysis
3.4.1. By type
3.4.2. By management
3.4.3. By age group
3.4.4. By distribution channel
3.5. Porter’s analysis
3.6. Competitive landscape, 2017
3.6.1. Strategy dashboard
3.7. PESTEL analysis
Chapter 4. Diabetic Retinopathy Market, By Type
4.1. Key segment trends
4.2. Proliferative diabetic retinopathy
4.2.1. Market size, by region, 2014-2025 (USD Million)
4.3. Non-proliferative retinopathy
4.3.1. Market size, by region, 2014-2025 (USD Million)
Chapter 5. Diabetic Retinopathy Market, By Age Group
5.1. Key segment trends
5.2. 40-49
5.2.1. Market size, by region, 2014-2025 (USD Million)
5.3. 50-64
5.3.1. Market size, by region, 2014-2025 (USD Million)
5.4. 65-74
5.4.1. Market size, by region, 2014-2025 (USD Million)
5.5. Others
5.5.1. Market size, by region, 2014-2025 (USD Million)
Chapter 6. Diabetic Retinopathy Market, By Management
6.1. Key segment trends
6.2. Anti-VEGF
6.2.1. Market size, by region, 2014-2025 (USD Million)
6.3. Intraocular Steroid Injection
6.3.1. Market size, by region, 2014-2025 (USD Million)
6.4. Laser Surgery
6.4.1.1. Market size, by region, 2014-2025 (USD Million)
6.5. Vitrectomy
6.5.1.1. Market size, by region, 2014-2025 (USD Million)
Chapter 7. Diabetic Retinopathy Market, By Distribution Channel
7.1. Key segment trends
7.2. Hospitals and pharmacies
7.2.1. Market size, by region, 2014-2025 (USD Million)
7.3. Eye Clinics
7.3.1. Market size, by region, 2014-2025 (USD Million)
7.4. Ambulatory surgical centers (ASCs)
7.4.1. Market size, by region, 2014-2025 (USD Million)
Chapter 8. Diabetic Retinopathy Market, By Region
8.1. Key regional trends
8.2. North America
8.2.1. Market size, by country, 2014-2025 (USD Million)
8.2.2. Market size, by type, 2014-2025 (USD Million)
8.2.3. Market size, by management, 2014-2025 (USD Million)
8.2.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.2.5. Market size, by age group, 2014-2025 (USD Million)
8.2.6. U.S.
8.2.6.1. Market size, by type, 2014-2025 (USD Million)
8.2.6.2. Market size, by management, 2014-2025 (USD Million)
8.2.6.3. Market size, by age group, 2014-2025 (USD Million)
8.2.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.2.7. Canada
8.2.7.1. Market size, by type, 2014-2025 (USD Million)
8.2.7.2. Market size, by management, 2014-2025 (USD Million)
8.2.7.3. Market size, by age group, 2014-2025 (USD Million)
8.2.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.3. Europe
8.3.1. Market size, by country, 2014-2025 (USD Million)
8.3.2. Market size, by type, 2014-2025 (USD Million)
8.3.3. Market size, by management, 2014-2025 (USD Million)
8.3.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.3.5. Market size, by age group, 2014-2025 (USD Million)
8.3.6. Germany
8.3.6.1. Market size, by type, 2014-2025 (USD Million)
8.3.6.2. Market size, by management, 2014-2025 (USD Million)
8.3.6.3. Market size, by age group, 2014-2025 (USD Million)
8.3.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.3.7. UK
8.3.7.1. Market size, by type, 2014-2025 (USD Million)
8.3.7.2. Market size, by management, 2014-2025 (USD Million)
8.3.7.3. Market size, by age group, 2014-2025 (USD Million)
8.3.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.3.8. France
8.3.8.1. Market size, by type, 2014-2025 (USD Million)
8.3.8.2. Market size, by management, 2014-2025 (USD Million)
8.3.8.3. Market size, by age group, 2014-2025 (USD Million)
8.3.8.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.3.9. Italy
8.3.9.1. Market size, by type, 2014-2025 (USD Million)
8.3.9.2. Market size, by management, 2014-2025 (USD Million)
8.3.9.3. Market size, by age group, 2014-2025 (USD Million)
8.3.9.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.3.10. Spain
8.3.10.1. Market size, by type, 2014-2025 (USD Million)
8.3.10.2. Market size, by management, 2014-2025 (USD Million)
8.3.10.3. Market size, by age group, 2014-2025 (USD Million)
8.3.10.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.4. Asia Pacific
8.4.1. Market size, by country, 2014-2025 (USD Million)
8.4.2. Market size, by type, 2014-2025 (USD Million)
8.4.3. Market size, by management, 2014-2025 (USD Million)
8.4.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.4.5. Market size, by age group, 2014-2025 (USD Million)
8.4.6. China
8.4.6.1. Market size, by type, 2014-2025 (USD Million)
8.4.6.2. Market size, by management, 2014-2025 (USD Million)
8.4.6.3. Market size, by age group, 2014-2025 (USD Million)
8.4.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.4.7. India
8.4.7.1. Market size, by type, 2014-2025 (USD Million)
8.4.7.2. Market size, by management, 2014-2025 (USD Million)
8.4.7.3. Market size, by age group, 2014-2025 (USD Million)
8.4.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.4.8. Japan
8.4.8.1. Market size, by type, 2014-2025 (USD Million)
8.4.8.2. Market size, by management, 2014-2025 (USD Million)
8.4.8.3. Market size, by age group, 2014-2025 (USD Million)
8.4.8.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.4.9. Australia
8.4.9.1. Market size, by type, 2014-2025 (USD Million)
8.4.9.2. Market size, by management, 2014-2025 (USD Million)
8.4.9.3. Market size, by age group, 2014-2025 (USD Million)
8.4.9.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.4.10. South Korea
8.4.10.1. Market size, by type, 2014-2025 (USD Million)
8.4.10.2. Market size, by management, 2014-2025 (USD Million)
8.4.10.3. Market size, by age group, 2014-2025 (USD Million)
8.4.10.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.5. Latin America
8.5.1. Market size, by country, 2014-2025 (USD Million)
8.5.2. Market size, by type, 2014-2025 (USD Million)
8.5.3. Market size, by management, 2014-2025 (USD Million)
8.5.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.5.5. Market size, by age group, 2014-2025 (USD Million)
8.5.6. Brazil
8.5.6.1. Market size, by type, 2014-2025 (USD Million)
8.5.6.2. Market size, by management, 2014-2025 (USD Million)
8.5.6.3. Market size, by age group, 2014-2025 (USD Million)
8.5.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.5.7. Mexico
8.5.7.1. Market size, by type, 2014-2025 (USD Million)
8.5.7.2. Market size, by management, 2014-2025 (USD Million)
8.5.7.3. Market size, by age group, 2014-2025 (USD Million)
8.5.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.5.8. Argentina
8.5.8.1. Market size, by type, 2014-2025 (USD Million)
8.5.8.2. Market size, by management, 2014-2025 (USD Million)
8.5.8.3. Market size, by age group, 2014-2025 (USD Million)
8.5.8.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.6. MEA
8.6.1. Market size, by country, 2014-2025 (USD Million)
8.6.2. Market size, by type, 2014-2025 (USD Million)
8.6.3. Market size, by management, 2014-2025 (USD Million)
8.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.6.5. Market size, by age group, 2014-2025 (USD Million)
8.6.6. South Africa
8.6.6.1. Market size, by type, 2014-2025 (USD Million)
8.6.6.2. Market size, by management, 2014-2025 (USD Million)
8.6.6.3. Market size, by age group, 2014-2025 (USD Million)
8.6.6.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.6.7. Saudi Arabia
8.6.7.1. Market size, by type, 2014-2025 (USD Million)
8.6.7.2. Market size, by management, 2014-2025 (USD Million)
8.6.7.3. Market size, by age group, 2014-2025 (USD Million)
8.6.7.4. Market size, by distribution channel, 2014-2025 (USD Million)
8.6.8. UAE
8.6.8.1. Market size, by type, 2014-2025 (USD Million)
8.6.8.2. Market size, by management, 2014-2025 (USD Million)
8.6.8.3. Market size, by age group, 2014-2025 (USD Million)
8.6.8.4. Market size, by distribution channel, 2014-2025 (USD Million)
Chapter 9. Company Profiles
9.1. Bayer Healthcare
9.1.1. Business overview
9.1.2. Financial data
9.1.3. Product landscape
9.1.4. Strategic outlook
9.1.5. SWOT analysis
9.2. Novartis AG
9.2.1. Business overview
9.2.2. Financial data
9.2.3. Product landscape
9.2.4. Strategic outlook
9.2.5. SWOT analysis
9.3. Regeneron Pharmaceuticals Inc.
9.3.1. Business overview
9.3.2. Financial data
9.3.3. Product landscape
9.3.4. Strategic outlook
9.3.5. SWOT analysis
9.4. Allergan plc
9.4.1. Business overview
9.4.2. Financial data
9.4.3. Product landscape
9.4.4. Strategic outlook
9.4.5. SWOT analysis
9.5. ThromboGenics NV
9.5.1. Business overview
9.5.2. Financial data
9.5.3. Product landscape
9.5.4. Strategic outlook
9.5.5. SWOT analysis
9.6. Sirnaomics, Inc.
9.6.1. Business overview
9.6.2. Financial data
9.6.3. Product landscape
9.6.4. Strategic outlook
9.6.5. SWOT analysis
9.7. Genentech
9.7.1. Business overview
9.7.2. Financial data
9.7.3. Product landscape
9.7.4. Strategic outlook
9.7.5. SWOT analysis
9.8. Alimera Sciences
9.8.1. Business overview
9.8.2. Financial data
9.8.3. Product landscape
9.8.4. Strategic outlook
9.8.5. SWOT analysis
9.9. Ampio Pharmaceuticals
9.9.1. Business overview
9.9.2. Financial data
9.9.3. Product landscape
9.9.4. Strategic outlook
9.9.5. SWOT analysis
9.10. BCN Peptides
9.10.1. Business overview
9.10.2. Financial data
9.10.3. Product landscape
9.10.4. Strategic outlook
9.10.5. SWOT analysis
9.11. Kowa Group
9.11.1. Business overview
9.11.2. Financial data
9.11.3. Product landscape
9.11.4. Strategic outlook
9.11.5. SWOT analysis
